Singapore markets open in 6 hours 33 minutes
Straits Times Index
3,289.42 -23.93 (-0.72%) S&P 500
5,301.83 +55.15 (+1.05%) Dow
39,830.94 +272.83 (+0.69%) Nasdaq
16,732.29 +221.11 (+1.34%) Bitcoin USD
65,319.53 +3,967.18 (+6.47%) CMC Crypto 200
1,373.56 +105.62 (+8.33%)
Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:26PM EDT. Market open.
| Previous close | 428.59 |
| Open | 431.00 |
| Bid | 437.37 x 100 |
| Ask | 438.14 x 100 |
| Day's range | 428.62 - 439.15 |
| 52-week range | 320.01 - 448.40 |
| Volume | |
| Avg. volume | 1,023,132 |
| Market cap | 113.289B |
| Beta (5Y monthly) | 0.39 |
| PE ratio (TTM) | 28.36 |
| EPS (TTM) | 15.43 |
| Earnings date | 30 Jul 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 467.42 |
Business WireJennifer Schneider Elected to Vertex Board of Directors
BOSTON, May 15, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Jennifer Schneider, M.D., M.S., has been elected to its Board of Directors as an independent director. Dr. Schneider has more than two decades of experience in the health care industry as a physician, scientist and health care executive. She co-founded and serves as Chief Executive Officer of Homeward Health, a company committed to rearchitecting the delivery of health and care for nearly 60 million Ame
ZacksHere's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
GuruFocus.comAlpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
© 2024 Yahoo. All rights reserved.